Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Second 100 days Campaign under Saksham Niveshak Yojnamore...
Newspaper publication regarding special window for re-lodgement of transfer request and dematerialisation of physical shares.more...
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Titan Biotech Ltd...more...
Newspaper advertisement for Loss of Share Certificatemore...
As of March 2026 55.78% is owned by Indian Promoters and 44.22% by Public. Top five Promoters holding highest number of shares of Titan Biotech compa...more...
Compliance Certificate under Regn 74(5) of SEBI (DP) Regulations 2018more...
Intimation pertaining to credit confirmation of Equity Shares from the depositories regarding Sub-Division/Split of Equity Shares of the Company.more...
Please find attached herewith report for the period from 01.01.2026 to 06.01.2026 pertaining to re-lodgment of transfer of physical sharesmore...
Unaudited Financial Results (Standalone & Consolidated) for the third quarter and Nine Months Ended December 31 2025more...
The company reported standalone net profit of Rs 7.87 crore for the quarter ended December 31 2025 as compared to Rs 3.80 crore in the same period la...more...
Outcome of the board meeting held on 12th February 2026.more...
Activation of New ISIN for Sub-Division of Equity Shares of the Company.more...
Special Window for Transfer and Dematerialisation of Physical Securitiesmore...
Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and app...more...
Newspaper Advertisement submission for inviting claims or objection for transfer of physical Shares under Special Windowmore...
As of December 2025 55.78% is owned by Indian Promoters and 44.22% by Public. Top five Promoters holding highest number of shares of Titan Biotech Lt...more...
Please find attached herewith report for the month of December 2025 pertaining to re-lodgements of transfer of Physical Sharesmore...
Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for quarter ended 31st December 2025more...
Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 pertaining to change in Composition...more...
BOARD MEETINGS Company Name : Aakaar Medical Tech Date : 15-05-2026